Monopar Therapeutics Inc.MNPRNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-2.54%
↑ 44% above average
Average (9y)
-4.51%
Historical baseline
Range
High:-0.06%
Low:-31.86%
CAGR
+52.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -2.54% | +92.0% |
| 2023 | -31.86% | -564.2% |
| 2022 | -4.80% | -31.2% |
| 2021 | -3.66% | -162.9% |
| 2020 | -1.39% | -304.9% |
| 2019 | -0.34% | -64.2% |
| 2018 | -0.21% | -9.9% |
| 2017 | -0.19% | -108.0% |
| 2016 | -0.09% | -55.4% |
| 2015 | -0.06% | - |